So with a potential consumer market of "2 million specialty injection drug users worldwide"...& a price of $120 per unit...the total potential global market ASFX is going to be tapping into with this new unique product is $240M.
So over the course of the next year if they could tap into 1% of the global market that'd add up to $2.4M in revs. So at least it's a fresh revenue generating development...but we have no clue what ASFX's potential profit margin is glta